19.05 USD
↗ 0.53 (2.86%)AT CLOSE (11:59 AM EDT)
Kardigan, Inc. Common Stock
KARDNASDAQ • USD
19.05
↘ 0.01 (0.03%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
19.05
↘ 0.01 (0.03%)
Market: CLOSED
Kardigan, Inc. Common Stock (KARD) is currently trading at $18.98. Technical indicators currently signal "Strong Sell". Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Sep 14, 2026.
Open?$18.59
High?$19.39
Low?$17.77
Prev. Close?$18.52
Volume?806.6K
Avg. Volume?N/A
VWAP?$18.70
Bid / Ask
Bid?$14.62 × 100
Ask?$23.39 × 100
Spread?$8.77
Midpoint?$19.01
Valuation & Ratios
Market Cap?1.7B
Shares Out?N/A
Float?65.3M
Float %?74.5%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
Employees
N/A
Market Cap
1.7B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2026-06-18
Address
C/O KARDIGAN, INC.
SOUTH SAN FRANCISCO, CA 94080
Phone: (415) 573-3220
SOUTH SAN FRANCISCO, CA 94080
Phone: (415) 573-3220
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?3.38%Low
Short Interest?2.2M
Days to Cover?9.1
Free Float65.3M
Avg Daily Volume242.3K
Settlement Date2026-08-31